Live Breaking News & Updates on Optumrx Nationalpt Committee

Stay updated with breaking news from Optumrx nationalpt committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'No need' to suspend immunosuppressive drugs due to COVID-19: No impact on risk outcomes


Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
It is only natural that individuals taking immunosuppressive medications would fear COVID-19.
However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization.
“This is a small amount of good news at a time in this pandemic when we need it,”
G. Caleb Alexander, MD, MS
, told H
ealio Rheumatology. “Doctors and patients may have been deciding to discontinue these medications to this point. We are starting to see that there is no need for this.” ....

United States , Kayte Andersen , Rob Volansky , Johns Hopkins , G Caleb Alexander , Johns Hopkins University , Central Nervous System Advisory Committee , Blood Institute Pharmacoepidemiology , Training Program , Optumrx Nationalpt Committee , Johns Hopkins Bloomberg School Of Public Health , Johns Hopkins Bloomberg School Department Of Epidemiology , National Heart , Monument Analytics , Johns Hopkins Bloomberg School , Johns Hopkins Medicine , Clinical Infectious Diseases , Public Health , Drug Safety , Caleb Alexander , ஒன்றுபட்டது மாநிலங்களில் , ஜான்ஸ் ஹாப்கின்ஸ் , க் காலேப் அலெக்சாண்டர் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , பயிற்சி ப்ரோக்ர்யாம் , ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளி ஆஃப் பொது ஆரோக்கியம் ,